Divestment of BioPhausia AB (SE) to Karo Pharma AB (SE) by Medivir AB (SE) — Enterprice value SEK 908 million

Carnegie acted as financial adviser to Medivir AB (publ) in the divestment of BioPhausia AB to Karo Pharma AB (publ). BioPhausia consists of thirteen established pharmaceutical drugs with strong brand names and long prescription traditions in the Nordics. December 2016.